The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open‐labeled randomized controlled trial
- 15 April 2021
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 35 (7) , 3781-3791
Abstract
The present study aimed to evaluate the efficacy of flaxseed supplementation in the management of metabolic syndrome (MetS)‐related parameters among the patients with mild‐to‐moderate ulcerative colitis (UC). A randomized controlled clinical trial was conducted on 70 patients with UC. Participants were randomized in the intervention group, which received 30 g/day ground flaxseed powder or control group. Anthropometric and biochemical variables were assessed at the beginning and end of 12 weeks of intervention. Of the 70 patients enrolled in this study, 64 subjects were included in the final analysis. From baseline to 12 weeks' intervention, flaxseed supplementation resulted in a significant reduction in the serum concentration of insulin (p < .001), HOMA‐IR (p < .001), triglyceride (p = .001), total cholesterol (p < .001), and significant increase in the serum levels of HDL (p = .008). Also, we found a significant improvement in the SCCAI score (p < .001), TNF‐α (p = .03), and CRP (p < .001) following the flaxseed supplementation. However, we not observed any significant differences between two groups regarding the body weight, BMI, waist circumferences, systolic, and diastolic blood pressure (p > .05). Overall, 12 weeks of flaxseed supplementation resulted in greater improvement in the some MetS‐related parameters.Keywords
Funding Information
- Shahid Beheshti University of Medical Sciences (15676322)
This publication has 50 references indexed in Scilit:
- Selection of the appropriate method for the assessment of insulin resistanceBMC Medical Research Methodology, 2011
- Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanismsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effectsHuman Molecular Genetics, 2010
- In Vitro Bile Acid Binding and Short-Chain Fatty Acid Profile of Flax Fiber and Ethanol Co-ProductsJournal of Medicinal Food, 2009
- N-3 polyunsaturated fatty acid regulation of hepatic gene transcriptionCurrent Opinion in Lipidology, 2008
- Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usageAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over TrialPLOS ONE, 2007
- Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell systemMetabolism, 2006
- Evolving knowledge and therapy of inflammatory bowel diseaseNature Reviews Drug Discovery, 2006